Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib in Polymyalgia Rheumatica
NCT04799262Phase 2Completed
- Sponsor
- Renji Hospital
- Start
- Jan 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tofacitinib oral solution in polymyalgia rheumatica (PMR), sponsored by Renji Hospital. Started Jan 2021; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
polymyalgia rheumatica (PMR)
Beyond the preview
Go deeper on NCT04799262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04799262.